1. Home
  2. SLRX vs SPRC Comparison

SLRX vs SPRC Comparison

Compare SLRX & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLRX
  • SPRC
  • Stock Information
  • Founded
  • SLRX N/A
  • SPRC 2004
  • Country
  • SLRX United States
  • SPRC Israel
  • Employees
  • SLRX N/A
  • SPRC N/A
  • Industry
  • SLRX Biotechnology: Pharmaceutical Preparations
  • SPRC Biotechnology: Pharmaceutical Preparations
  • Sector
  • SLRX Health Care
  • SPRC Health Care
  • Exchange
  • SLRX Nasdaq
  • SPRC Nasdaq
  • Market Cap
  • SLRX 2.5M
  • SPRC 2.4M
  • IPO Year
  • SLRX N/A
  • SPRC N/A
  • Fundamental
  • Price
  • SLRX $1.37
  • SPRC $0.25
  • Analyst Decision
  • SLRX
  • SPRC
  • Analyst Count
  • SLRX 0
  • SPRC 0
  • Target Price
  • SLRX N/A
  • SPRC N/A
  • AVG Volume (30 Days)
  • SLRX 42.5K
  • SPRC 463.0K
  • Earning Date
  • SLRX 11-14-2024
  • SPRC 12-03-2024
  • Dividend Yield
  • SLRX N/A
  • SPRC N/A
  • EPS Growth
  • SLRX N/A
  • SPRC N/A
  • EPS
  • SLRX N/A
  • SPRC N/A
  • Revenue
  • SLRX N/A
  • SPRC $1,747,000.00
  • Revenue This Year
  • SLRX N/A
  • SPRC N/A
  • Revenue Next Year
  • SLRX N/A
  • SPRC N/A
  • P/E Ratio
  • SLRX N/A
  • SPRC N/A
  • Revenue Growth
  • SLRX N/A
  • SPRC N/A
  • 52 Week Low
  • SLRX $1.26
  • SPRC $0.21
  • 52 Week High
  • SLRX $7.27
  • SPRC $14.22
  • Technical
  • Relative Strength Index (RSI)
  • SLRX 41.48
  • SPRC 66.10
  • Support Level
  • SLRX $1.37
  • SPRC $0.22
  • Resistance Level
  • SLRX $1.44
  • SPRC $0.24
  • Average True Range (ATR)
  • SLRX 0.07
  • SPRC 0.02
  • MACD
  • SLRX -0.01
  • SPRC 0.00
  • Stochastic Oscillator
  • SLRX 15.61
  • SPRC 98.10

About SLRX Salarius Pharmaceuticals Inc.

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: